Antiviral Drug News and Research

RSS

HHS purchases 1.2 million doses of GSK's Fluarix flu vaccine

HHS Secretary Tommy G. Thompson has announced that the Food and Drug Administration authorized the use of GlaxoSmithKline influenza vaccine, Fluarix, in the United States under an Investigational New Drug application.

8 Dec 2004

Animal model helps explain how AIDS virus spreads throughout the body following oral exposure

Researchers at UT Southwestern Medical Center at Dallas have utilized an animal model to trace how the virus that causes AIDS in humans may enter and spread throughout the body following an oral exposure.

3 Dec 2004

Viral Genetics announces effects of VGV-1 in antiretroviral non-responding HIV infections

Viral Genetics announced today that the results of a clinical trial of its investigational therapy for HIV infection, VGV-1, were recently published in a peer reviewed journal, HIV & AIDS Review.

29 Nov 2004

Eisai In-licenses Anti-hepatitis B Agent clevudine From Bukwang Pharm

Eisai Co., Ltd. announced today that the Company has in-licensed an anti-hepatitis B agent (generic name: clevudine) from Bukwang Pharm (Headquarters, Seoul, South Korea, President: Sung-Koo Lee).

16 Nov 2004

Computer models to combat the H5N1 strain of the bird influenza virus

A group of scientists who are developing computer models to combat infectious diseases have focused their attention on the H5N1 strain of the bird influenza virus.

16 Nov 2004

Morton Grove Pharmaceuticals increases production of antiviral flu drug, Amantadine

During the current flu vaccine shortage, the Centers for Disease Control and Prevention, Department of Health and Human Services, has issued guidance recommending the use of certain alternative antiviral medications.

8 Nov 2004

New approaches for the treatment of chronic hepatitis C

Data from two ongoing studies testing new approaches for the treatment of chronic hepatitis C was presented at the annual meeting of the American Association for the Study of Liver Diseases (AASLD) this afternoon.

1 Nov 2004

Tamiflu significantly reduced the risk of pneumonia in patients diagnosed with flu

Treatment with the antiviral medication Tamiflu (oseltamivir phosphate) significantly reduced the risk of pneumonia in patients diagnosed with flu, according to a new retrospective cohort study of over 70,000 Americans.

1 Nov 2004

U.S. Department of Health & Human Services has announced progress toward expanding the nation's supply of vaccines for flu season

The Food and Drug Administration (FDA) has identified about 5 million doses of influenza vaccine from foreign manufacturers; HHS has been able to recoup an additional 300,000 doses of the injectable vaccine originally bought for federal employees and the military; and a major pneumonia vaccine manufacturer plans to triple its production.

29 Oct 2004

New law will help stop litigation abuse against vaccines

U.S. Senator Larry Craig announced that legislation will be signed into law in a few days by President Bush which will help avert future flu vaccine shortages.

21 Oct 2004

Expert says it is unlikely bird flu will reach Canada

United Nations officials warn the outbreak of bird flu is far from over and continues to spread in Thailand and Vietnam. An expert at The University of Western Ontario says it is unlikely the disease will reach Canada but travellers should take precautions.

5 Oct 2004

Significant progress in development of an animal model of smallpox that closely resembles human disease

Scientists have made significant progress in developing an animal model of smallpox that closely resembles human disease, which will be necessary for testing of future vaccines and potential treatments.

5 Oct 2004

Bristol-Myers Squibb submits New Drug Application to the U.S. Food and Drug Administration for entecavir

Bristol-Myers Squibb has announced the submission of a New Drug Application to the U.S. Food and Drug Administration for entecavir, an investigational antiviral agent under development for the treatment of chronic Hepatitis B.

4 Oct 2004

Lassa Fever, not seen in US for 15 years re-emerges

The New Jersey Department of Health and Senior Services reported today that a 38-year-old Mercer County man died on August 28 from an acute viral disease called Lassa fever, a condition that is rare in the U.S., but endemic to West Africa.

23 Sep 2004

Allow genomic information to be freely available on the internet

This week’s lead editorial in THE LANCET discusses the benefits and potential risks of allowing genomic information to be freely available on the internet

23 Sep 2004

Promising lead in developing anti-viral drugs with the potential to fight HIV and HSV

Dr Norelle Daly, from UQ’s Institute for Molecular Bioscience, is looking at the molecular structure of retrocyclin, a molecule with the ability to protect human cells from HIV infection.

23 Sep 2004

THC in marijuana may block the spread of forms of cancer causing herpes viruses

The compound in marijuana that produces a high, delta-9 tetrahydrocannbinol or THC, may block the spread of several forms of cancer causing herpes viruses, University of South Florida College of Medicine scientists report.

22 Sep 2004

Aventis Pasteur to manufacture and store 2 million doses of avian influenza H5N1 vaccine

HHS Secretary Tommy G. Thompson has announced the awarding of a contract to Aventis Pasteur Inc. to manufacture and store 2 million doses of avian influenza H5N1 vaccine

22 Sep 2004

New diagnostic tests for bird flu

On the final day of the recent HPA conference, delegates heard about work that the Agency is carrying out to prepare for an avian flu pandemic.

16 Sep 2004

First molecular-scale images of DNA binding to an adenovirus enzyme

The images, which appear on the cover of the October 2004 issue of Molecular and Cellular Proteomics, show how binding to DNA may stimulate the enzyme and are already being used to design new antiviral drugs to block this interaction.

14 Sep 2004

Antiviral Drug News and Research

HHS purchases 1.2 million doses of GSK's Fluarix flu vaccine

Animal model helps explain how AIDS virus spreads throughout the body following oral exposure

Viral Genetics announces effects of VGV-1 in antiretroviral non-responding HIV infections

Eisai In-licenses Anti-hepatitis B Agent clevudine From Bukwang Pharm

Computer models to combat the H5N1 strain of the bird influenza virus

Morton Grove Pharmaceuticals increases production of antiviral flu drug, Amantadine

New approaches for the treatment of chronic hepatitis C

Tamiflu significantly reduced the risk of pneumonia in patients diagnosed with flu

U.S. Department of Health & Human Services has announced progress toward expanding the nation's supply of vaccines for flu season

New law will help stop litigation abuse against vaccines

Expert says it is unlikely bird flu will reach Canada

Significant progress in development of an animal model of smallpox that closely resembles human disease

Bristol-Myers Squibb submits New Drug Application to the U.S. Food and Drug Administration for entecavir

Lassa Fever, not seen in US for 15 years re-emerges

Allow genomic information to be freely available on the internet

Promising lead in developing anti-viral drugs with the potential to fight HIV and HSV

THC in marijuana may block the spread of forms of cancer causing herpes viruses

Aventis Pasteur to manufacture and store 2 million doses of avian influenza H5N1 vaccine

New diagnostic tests for bird flu

First molecular-scale images of DNA binding to an adenovirus enzyme

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News